← Back to headlines
Pfizer Sales Driven by Cancer Treatments as Covid Revenue Declines
Pfizer is experiencing sales growth primarily propelled by its cancer treatments, while revenue from Covid-related products continues to dwindle.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
